Get my own profile
Public access
View all39 articles
3 articles
available
not available
Based on funding mandates
Co-authors
- David WalshProfessor of Rheumatology, University of NottinghamVerified email at nottingham.ac.uk
- Dana SelleyProfessor of Pharmacology and Toxicology, Virginia Commonwealth UniversityVerified email at vcuhealth.org
- Jonathan Z. LongAssistant Professor, Stanford UniversityVerified email at stanford.edu
- Gareth HathwayProfessor of Neuroscience, University of NottinghamVerified email at nottingham.ac.uk
- Daniel NomuraProfessorVerified email at berkeley.edu
- Steven G KinseyUniversity of ConnecticutVerified email at uconn.edu
- Joel SchlosburgAssistant Professor of Pharmacology & Toxicology, Virginia Commonwealth UniversityVerified email at vcu.edu
- Peter GowlerResearch Fellow, University of NottinghamVerified email at nottingham.ac.uk
- D. Matthew WalentinyDepartment of Pharmacology & Toxicology, Virginia Commonwealth UniversityVerified email at vcu.edu
- Anu MahadevanOrganix, IncVerified email at organixinc.com
- Divya RameshRegeneron Pharmaceuticals Inc.Verified email at regeneron.com
- BE ScammellUniversity of NottinghamVerified email at nottingham.ac.uk
- MARY ABOODTemple UniversityVerified email at temple.edu
- Petros PousinisPostdoctoral researcher, BIOMIC AUTh, Aristotle University of Thessaloniki, GreeceVerified email at chem.auth.gr
- Lilian NwosuSanofi, Cambridge, UKVerified email at sanofi.com
- Vincenzo Di MarzoConsiglio nazionale delle RicercheVerified email at icb.cnr.it
- Mingfeng BaiVanderbilt University Medical CenterVerified email at vanderbilt.edu
Follow
James Burston
Phase 1 lead and lecturer, North Wales Medical School, Bangor University
Verified email at cardiff.ac.uk